Keyphrases
Antibody Treatment
14%
Antibody-mediated
14%
Brain Tumor
14%
Brain Tumor Surgery
14%
CCL5
14%
CD11a
100%
Cellular Constituents
14%
CX3CR1
42%
Different Datasets
14%
Directed Motility
14%
Disease-associated Microglia
28%
Gene-deficient Mice
14%
Genetically Engineered Mice
14%
Glioma
28%
Glioma Growth
100%
Glioma-associated Microglia
42%
Human Biospecimens
14%
Immunohistochemistry
14%
In Vitro Functional Studies
14%
ITGAL
100%
Knock-in Mouse Model
14%
Low-grade Glioma
100%
Meta-analysis
14%
Microglia
71%
Mitogen
14%
Monocytes
14%
Mouse in Vivo
14%
Mouse Strain
14%
Murine Model
14%
Neurofibromatosis Type 1 (NF-1)
42%
Neurofibromatosis Type I
42%
Neutralizing Antibodies
14%
Non-neoplastic
28%
Optic Pathway Glioma
28%
Pilocytic Astrocytoma
14%
Publicly Available
14%
RNA Sequencing (RNA-seq)
14%
RNA-seq Analysis
100%
RNA-seq Datasets
14%
RNAscope
14%
Treatment Strategy
14%
Tumor
14%
Tumor Microenvironment
14%
Unique Populations
14%
Medicine and Dentistry
Cancer Treatment
8%
Diseases
16%
Ganglioglioma
100%
Immunohistochemistry
8%
In Vitro
8%
Intracranial Tumor
16%
Meta-Analysis
8%
Microglia
83%
Mitogenic Agent
8%
Neoplasm
8%
Neurofibromatosis Type I
25%
Neutralizing Antibody
8%
Optic Nerve Glioma
16%
Pilocytic Astrocytoma
8%
Protein Sequencing
100%
Receptor
8%
RNA Sequence
8%
RNA Sequencing
8%
Sequence Analysis
100%
Stroma
8%
Tumor Microenvironment
8%
Neuroscience
CD11a
70%
CX3CL1
20%
Immunohistochemistry
10%
In Vitro
10%
In Vivo
20%
Intracranial Tumor
20%
Low-Grade Glioma
100%
Meta-Analysis
10%
Microglia
100%
Neurofibromatosis Type 1
30%
Neutralizing Antibody
10%
Pilocytic Astrocytoma
10%
Protein Sequencing
100%
Receptor
10%
RNA Sequence
10%
RNA-Seq
10%